Abstract
The mode of action of a series of 2-(4-dihydropyrrolylthiazol-2-ylthio) and 2-(4-tetrahydropyridinylthiazol-2-ylthio)-1β-methylcarbapenem analogues against Pseudomonas aeruginosa was investigated with regard to contributions of the affinity for penicillin binding proteins (PBPs), the outer membrane permeability, and the effect of the MexAB-OprM efflux system. In this series of carbapenems, the introduction of a substituent in C-2 side chain with a change in physicochemical properties affected the antipseudomonal activity depending on the molecular weight. However, these structural modifications did not affect the affinity for pseudomonal PBPs significantly. It was confirmed that the affinity for PBPs was not an important determinant of the antipseudomonal activity of this series of carbapenems. OprD porin-deficiency did not affect antipseudomonal activity either. On the other hand, the MIC of these carbapenems against P. aeruginosa significantly decreased in the presence of outer membrane permeabilizer. This result strongly suggests that the cause of the relatively low antipseudomonal activity of these carbapanems is their low permeability through the outer membrane of P. aeruginosa. And also, in the presence of outer membrane permeabilizer, the MICs against MexAB-OprM deficient mutants remarkably decreased and were very close to the value of the IC50 for pseudomonal PBPs. From this result, it was clear that the effect of the MexAB-OprM efflux system was also an important determinant of antipseudomonal activity of these carbapenems. In conclusion, the major determinants of the antipseudomonal activity of the 2-(thiazol-2-ylthio)-1β-methylcarbapenems are the outer membrane permeability and the effect of the MexAB-OprM efflux system, not the affinity for pseudomonal PBPs.
Similar content being viewed by others
Article PDF
References
Arakawa Y, Ike Y, Nagasawa M, Shibata N, Doi Y, Shibayama K, Yagi T, Kurata T . Trends in antimicrobial-drug resistance in Japan. Emerg Infect Dis 6: 572–575 ( 2000)
Jones RN . Resistance patterns among nosocomial pathogens: trends over the past few years. Chest 119: 397S–404S ( 2001)
Ueda Y, Kanazawa K, Eguchi K, Takemoto K, Eriguchi Y, Sunagawa M . In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem. Antimicrob Agents Chemother 49: 4185–4196 ( 2005)
Ueda Y, Itoh M, Sasaki A, Sunagawa M . SM-216601, a novel parenteral 1β-methylcarbapenem: structure-activity relationships of antibacterial activity and neurotoxicity in mice. J Antibiot 58: 118–140 ( 2005)
Sumita Y, Yamaga H, Sunagawa M . The effect of 1β-methyl substituent and the basicity in C-2 side chain in carbapenem antibiotics on the activity against Pseudomonas aeruginosa oprD2 and nalB mutants. J Antibiot 48: 89–91 ( 1995)
Zhao G, Meier TI, Kahl SD, Gee KR, Blaszczak LC . BOCILLIN FL, a sensitive and commercially available reagent for detection of penicillin-binding proteins. Antimicrob Agents Chemother 43: 1124–1128 ( 1999)
Morikawa Y, Kitazato M, Mitsuyama J, Mizunaga S, Minami S, Watanabe Y . In vitro activities of piperacillin against β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 48: 1229–1234 ( 2004)
Sumita Y, Fukasawa M, Okuda T . Comparison of two carbapenems, SM-7338 and imipenem: affinities for penicillin-binding proteins and morphological changes. J Antibiot 43: 314–320 ( 1990)
National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-fifth edition. National Committee for Clinical Laboratory Standards 20: M7–A5 ( 2000)
Kahan FM, Kropp H, Sundelof JG, Birnbaum J . Thienamycin: development of imipenen-cilastatin. J Antimicrob Chemother 12 ( Suppl D): 1–35 ( 1983)
Gotoh N, Nishino T . Decreases of the susceptibility to low molecular weight β-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusion. J Antimicrob Chemother 25: 191–198 ( 1990)
Nagao Y, Nagase Y, Kumagai T, Matsunaga H, Abe T, Shimada O, Hayashi T, Inoue Y . β-Lactams. 3. Asymmetric total synthesis of new non-natural 1β-methylcarbapenems exhibiting strong antimicrobial activities and stability against human renal dehydropeptidase-I. J Org Chem 57: 4243–4249 ( 1992)
Trias J, Nikaido H . Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 34: 52–57 ( 1990)
Li XZ, Ma D, Livermore DM, Nikaido H . Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to β-lactam resistance. Antimicrob Agents Chemother 38: 1742–1752 ( 1994)
Li XZ, Nikaido H, Poole K . Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother 39: 1948–1953 ( 1995)
Livermore DM . Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother 47: 247–250 ( 2001)
Li XZ, Zhang L, Poole K . Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa. J Antimicrob Chemother 45: 433–436 ( 2000)
Vaara M . Agents that increase the permeability of the outer membrane. Microbiol Rev 56: 395–411 ( 1992)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eguchi, K., Ueda, Y., Kanazawa, K. et al. The Mode of Action of 2-(Thiazol-2-ylthio)-1β-methylcarbapenems against Pseudomonas aeruginosa: The Impact of Outer Membrane Permeability and the Contribution of MexAB-OprM Efflux System. J Antibiot 60, 129–135 (2007). https://doi.org/10.1038/ja.2007.12
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ja.2007.12
Keywords
This article is cited by
-
2,4-Disubstituted thiazoles as multitargated bioactive molecules
Medicinal Chemistry Research (2016)